<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Despite the backlash felt on equities, the valuation of many stocks still hovers at expensive premiums because of 2019’s historic run. Let’s take a look at a few stocks that trade at a more buyer friendly valuation. ” data-reactid=”19″>Despite the backlash felt on equities, the valuation of many stocks still hovers at expensive premiums because of 2019’s historic run. Let’s take a look at a few stocks that trade at a more buyer friendly valuation.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Best Buy BBY has been able to successfully fend off the onslaught of competition from not only other retailers, but from e-commerce giants like Amazon AMZN. The electronics retailer has done this by offering a variety of services like consultation, installation, and technical support. These initiatives have yielded positive results for the firm as Best Buy has boasted positive comparable sales since fiscal 2014. ” data-reactid=”20″>Best Buy BBY has been able to successfully fend off the onslaught of competition from not only other retailers, but from e-commerce giants like Amazon AMZN. The electronics retailer has done this by offering a variety of services like consultation, installation, and technical support. These initiatives have yielded positive results for the firm as Best Buy has boasted positive comparable sales since fiscal 2014.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Best Buy’s Total Tech Support system has also seen success as memberships have increased from 200,000 in May 2018 to 2 million. BBY stock currently trades for about 14X its forward earnings, which is below the S&P 500 average of about 19X forward earnings. Our Q4 consensus estimates call for earnings to rise 1.5% to $2.76 per share while net revenue grows over 2% to $15.1 billion. Best Buy boasts a Zacks Rank #2 (Buy) with a Style Score of A in Value. ” data-reactid=”21″>Best Buy’s Total Tech Support system has also seen success as memberships have increased from 200,000 in May 2018 to 2 million. BBY stock currently trades for about 14X its forward earnings, which is below the S&P 500 average of about 19X forward earnings. Our Q4 consensus estimates call for earnings to rise 1.5% to $2.76 per share while net revenue grows over 2% to $15.1 billion. Best Buy boasts a Zacks Rank #2 (Buy) with a Style Score of A in Value.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Sonic Automotive SAH is a stock that has more than doubled in the past 12 months and looks poised to continue its run in 2020. The company’s EchoPark initiative continued to yield successful results as it generated $312.2 million in revenue in Q3, which represented an increase of roughly 68% from the year ago quarter. ” data-reactid=”23″>Sonic Automotive SAH is a stock that has more than doubled in the past 12 months and looks poised to continue its run in 2020. The company’s EchoPark initiative continued to yield successful results as it generated $312.2 million in revenue in Q3, which represented an increase of roughly 68% from the year ago quarter.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="The strong performance its EchoPark business saw in the third quarter prompted management to raise its guidance for EchoPark’s fiscal 2019 total sales to $1.2 billion, which would be a 71% surge. SAH stock currently trades for a little over 10X its forward earnings, which is a solid entry point for a stock that carries momentum from 2019. Our Q4 consensus estimates forecast a top-line rally of 7.4% and a bottom-line hike of 15.8%. Sonic Automotive is listed as a Zacks Rank #1 (Strong Buy) with a Style Score of A in Value. ” data-reactid=”24″>The strong performance its EchoPark business saw in the third quarter prompted management to raise its guidance for EchoPark’s fiscal 2019 total sales to $1.2 billion, which would be a 71% surge. SAH stock currently trades for a little over 10X its forward earnings, which is a solid entry point for a stock that carries momentum from 2019. Our Q4 consensus estimates forecast a top-line rally of 7.4% and a bottom-line hike of 15.8%. Sonic Automotive is listed as a Zacks Rank #1 (Strong Buy) with a Style Score of A in Value.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="AbbVie ABBV has actively tried to diversify its product portfolio to better adapt its business to the contemporary pharma market. The company announced in June that it would acquire Allergan AGN, in an effort to diversify its revenue streams. The two companies expect the deal to close in early 2020, which could provide a boost for AbbVie. Allergan can add valuable diversification through its medical aesthetics and botox products. ” data-reactid=”26″>AbbVie ABBV has actively tried to diversify its product portfolio to better adapt its business to the contemporary pharma market. The company announced in June that it would acquire Allergan AGN, in an effort to diversify its revenue streams. The two companies expect the deal to close in early 2020, which could provide a boost for AbbVie. Allergan can add valuable diversification through its medical aesthetics and botox products.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="These added revenue streams would bode well for AbbVie as it weens itself off of Humira, which makes up more than half of its revenue. The dependency AbbVie has on Humira has worried investors as biosimilars have entered the European market and caused a decline in the drug’s sales. These worries have sent the stock to an opportune valuation for investors at about 9.5X its forward earnings. In addition, our Q4 estimates call for a top-line climb of 5.48% and a bottom-line gain of 19.5%. AbbVie currently sports a Zacks Rank #2 (Buy) with a Style Score of A in Growth. ” data-reactid=”27″>These added revenue streams would bode well for AbbVie as it weens itself off of Humira, which makes up more than half of its revenue. The dependency AbbVie has on Humira has worried investors as biosimilars have entered the European market and caused a decline in the drug’s sales. These worries have sent the stock to an opportune valuation for investors at about 9.5X its forward earnings. In addition, our Q4 estimates call for a top-line climb of 5.48% and a bottom-line gain of 19.5%. AbbVie currently sports a Zacks Rank #2 (Buy) with a Style Score of A in Growth.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Looking for Stocks with Skyrocketing Upside?” data-reactid=”28″>Looking for Stocks with Skyrocketing Upside?
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.” data-reactid=”30″>Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.” data-reactid=”32″>Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="See the pot trades we’re targeting>> ” data-reactid=”34″>See the pot trades we’re targeting>>
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sonic Automotive, Inc. (SAH) : Free Stock Analysis Report
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
Allergan plc (AGN) : Free Stock Analysis Report
AbbVie Inc. (ABBV) : Free Stock Analysis Report
Best Buy Co., Inc. (BBY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research” data-reactid=”35″>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sonic Automotive, Inc. (SAH) : Free Stock Analysis Report
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
Allergan plc (AGN) : Free Stock Analysis Report
AbbVie Inc. (ABBV) : Free Stock Analysis Report
Best Buy Co., Inc. (BBY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Add Comment